To Develop and Implement a Method for Optimizing the Volume of Lymph Node Dissection in Radical Surgical Treatment of Localized or Locally Advanced Prostate Cancer
This is a randomized controlled study assessing outcome of low (no or limited) versus high (limited or extended) extent of lymph node dissection in addition to radical prostatectomy in patients with operable localized or locally advanced prostate cancer.
• Age over 18 years.
• Histologically confirmed localized or locally advanced prostate cancer (adenocarcinoma without a neuroendocrine component).
• No evidence of metastatic spread of the tumor
• Local resectability of the tumor according to digital rectal examination and/or CT and/or MRI of the pelvis
• Patients are suitable for radical prostatectomy based on their comorbidities and life expectancy.
• Signed informed consent to participate in the study.